Finance

Lists
YARW:NASDAQ
Yarrow Bioscience Inc
$38.00
-4.13%
(-1.63) 1D
Aug 27, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for YARW...
Open
$39.08
High
$40.00
Low
$37.00
Mkt. cap
101.44M
Avg. vol.
20.99K
Volume
37.48K
52-wk high
$44.28
52-wk low
$26.47
EPS
-$21.85
Beta
2.01
Shares outstanding
2.67M
No. of employees
6
Open
$39.08
High
$40.00
Low
$37.00
Mkt. cap
101.44M
Avg. vol.
20.99K
Volume
37.48K
52-wk high
$44.28
52-wk low
$26.47
EPS
-$21.85
Beta
2.01
Shares outstanding
2.67M
No. of employees
6
About Yarrow Bioscience Inc
CEO-
Employees6
Founded2003
HeadquartersNew Haven, Connecticut, United States
SectorPharmaceutical industry
Websitevynetherapeutics.com
Analyst ratings
Based on 3 analysts giving stock ratings to YARW in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for YARW in the last 3 months.
Highest
Current $38.00
$58.00 (+52.63%)
Average
$57.00 (+50.00%)
Lowest
$56.00 (+47.37%)
Analyst
Recommendation
Action
Price target
Projected
Date
Rami Katkhuda
LifeSci Capital
Buy
Maintained
$56.00
+47.4%
08/13/2026
Julian Harrison
BTIG
Buy
Initiated
$58.00
+52.6%
08/03/2026
Stacy Ku
TD Cowen
Buy
Initiated
-
-
07/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
69.00K
169.00K
130.00K
86.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.88M
5.26M
2.98M
1.25M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.73M
2.70M
2.37M
1.62M
Operating expense
7.61M
7.96M
5.35M
2.86M
Total operating expenses
7.61M
7.96M
5.35M
2.86M
Operating income
-7.54M
-7.79M
-5.22M
-2.86M
Other non operating income
495.00K
366.00K
-1.45M
-
EBT including unusual items
-5.75M
-7.43M
-4.96M
-2.74M
EBT excluding unusual items
-7.05M
-7.43M
-4.96M
-3.58M
Income tax expense
-
-
4.00K
-
Effective tax rate
-
-
-0.08%
-
Other operating expenses
-
-
-
-
Net income
-5.76M
-7.28M
-4.84M
-2.74M
Net profit margin
-8,340.58%
-4,307.69%
-3,720.77%
-4,168.60%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1.72M
231.00K
Interest expense
-
-
-
-
Net interest expenses
-
-
1.72M
231.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.54M
-7.79M
-5.21M
-3.81M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps